Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ouyang

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 11, 2020
Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapyL Wang, Y Li, J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2018
Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancersX Chen, Y Li, T Ouyang, et al.
Zhonghua Yi Xue Za Zhi|June 9, 2017
[Impact of adjuvant chemotherapy on the prognosis of hormone receptor negative breast cancer with residual lymph node disease after neoadjuvant chemotherapy]X Wang, Y J He, J F Li, et al.
Zhonghua Yi Xue Za Zhi|February 6, 2018
[Application of decision curve on evaluation of MRI predictive model for early assessing pathological complete response to neoadjuvant therapy in breast cancer]Y J He, X T Li, Z Q Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 4, 2011
HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancerL Yao, Y Liu, Z Li, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 30, 2020
[Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy]L Z Wang, J F Li, T F Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2014
Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancerC Wang, J Zhang, Y Wang, et al.
Clinical Genetics|March 28, 2018
Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancerL Su, J Zhang, H Meng, et al.
Zhonghua Yi Xue Za Zhi|August 18, 2021
[Effect of axillary lymph node status on prognosis of different types of invasive breast cancer]Y J He, Z Q Fan, J F Li, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 7, 2017
[Breast-conserving surgery with immediate partial breast reconstruction using pedicled thoracodorsal artery perforator flap: a clinical analysis of 33 patients]X Wang, Y J He, J F Li, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 11, 2020
Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapyL Wang, Y Li, J Li, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2018
Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancersX Chen, Y Li, T Ouyang, et al.
Zhonghua Yi Xue Za Zhi|June 9, 2017
[Impact of adjuvant chemotherapy on the prognosis of hormone receptor negative breast cancer with residual lymph node disease after neoadjuvant chemotherapy]X Wang, Y J He, J F Li, et al.
Zhonghua Yi Xue Za Zhi|February 6, 2018
[Application of decision curve on evaluation of MRI predictive model for early assessing pathological complete response to neoadjuvant therapy in breast cancer]Y J He, X T Li, Z Q Fan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 4, 2011
HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancerL Yao, Y Liu, Z Li, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|December 30, 2020
[Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy]L Z Wang, J F Li, T F Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2014
Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancerC Wang, J Zhang, Y Wang, et al.
Clinical Genetics|March 28, 2018
Prevalence of BRCA1/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancerL Su, J Zhang, H Meng, et al.
Zhonghua Yi Xue Za Zhi|August 18, 2021
[Effect of axillary lymph node status on prognosis of different types of invasive breast cancer]Y J He, Z Q Fan, J F Li, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 7, 2017
[Breast-conserving surgery with immediate partial breast reconstruction using pedicled thoracodorsal artery perforator flap: a clinical analysis of 33 patients]X Wang, Y J He, J F Li, et al.
Pageof 4